Ceeto Capital Group’s Novo Nordisk NVO Stock Holding History

Ceeto Capital Group’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,206	Closed	-$112K	–	181
2025 Q4	$112K	Hold	2,206	–	–	0.03%	180
2025 Q3	$122K	Hold	2,206	–	–	0.04%	178
2025 Q2	$152K	Hold	2,206	–	–	0.05%	164
2025 Q1	$156K	Hold	2,206	–	–	0.06%	159
2024 Q4	$190K	Hold	2,206	–	–	0.07%	150
2024 Q3	$263K	Hold	2,206	–	–	0.1%	139
2024 Q2	$315K	Hold	2,206	–	–	0.12%	123
2024 Q1	$285K	Hold	2,206	–	–	0.12%	137
2023 Q4	$228K	Hold	2,206	–	–	0.1%	145
2023 Q3	$201K	Hold	2,206	–	–	0.1%	143
2023 Q2	$178K	Hold	2,206	–	–	0.08%	146
2023 Q1	$177K	Hold	2,206	–	–	0.09%	148
2022 Q4	$149K	Buy	+2,206	New	+$129K	0.08%	150

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Ceeto Capital Group's NVO Position: Q1 2026 in Review

Ceeto Capital Group sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 2,206 shares — an estimated $112K sold.

Ceeto Capital Group first reported a position in NVO in Q4 2022 and held it in 13 quarters. The position peaked at $315K in Q2 2024. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Ceeto Capital Group reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
Ceeto Capital Group sold 2,206 Novo Nordisk shares in Q1 2026, an estimated $112K.
Ceeto Capital Group first reported a position in Novo Nordisk in Q4 2022 and held it in 13 quarters.
Ceeto Capital Group's Novo Nordisk position peaked at $315K in Q2 2024.
1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Ceeto Capital Group's 13F filing for Q1 2026, filed 14 May 2026.